newsfilter
← Latest News
GlobeNewswire·

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference

MELBOURNE, Australia and SAN FRANCISCO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing